Corpus Intelligence IC Memo — POST ACUTE MEDICAL TULSA 2026-04-26 08:03 UTC
IC Memo — POST ACUTE MEDICAL TULSA
Investment Committee Memorandum | OK | 60 beds | Grade D | EBITDA uplift $1.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

POST ACUTE MEDICAL TULSA

CCN 372018 | TULSA, OK | 60 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

POST ACUTE MEDICAL TULSA is a 60-bed rural/critical access in TULSA, OK with $23.5M in net patient revenue and a 11.1% operating margin. The hospital serves a payer mix of 67.3% Medicare, 7.2% Medicaid, and 25.5% commercial.

Thesis: Turnaround. Our ML models identify $1.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.1% to 18.4% (+736bps).

Net Revenue HCRIS$23.5M
Current EBITDA COMPUTED$2.6M
Operating Margin COMPUTED11.1%
Occupancy HCRIS57.7%
Revenue / Bed COMPUTED$392K
Net-to-Gross HCRIS20.3%
Distress Probability ML48.8%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
66
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of 11.1% places it above the state median. Among 66 size-comparable peers (30-120 beds), the median margin is -4.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (30-120), prioritizing same-state peers. 66 hospitals in the comp set.

HospitalStateBedsRevenueMargin
POST ACUTE MEDICAL TULSA (Target)OK60$23.5M11.1%
OKLAHOMA HEART HOSPITALOK97$342.0M-2.8%
STILLWATER MEDICAL CENTEROK52$270.2M-9.9%
SAINT FRANCIS HOSPITAL SOUTHOK104$198.3M34.4%
ST ANTHONY SHAWNEE HOSPITALOK57$169.2M-6.1%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
OKLAHOMA HEART HOSPITAL SOUTHOK43$148.5M-0.6%
OKLAHOMA SURGICAL HOSPITALOK74$146.2M17.7%
COMMUNITY HOSPITALOK45$143.9M21.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$495K+210bp18mo
Cost to Collect4.5%2.5%$471K+200bp12mo
Denial Rate Reduction12.0%6.5%$466K+198bp12mo
A/R Days Reduction5200.0%3800.0%$287K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$495K
Cost to Collect
$471K
Denial Rate Reduction
$466K
A/R Days Reduction
$287K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.7M
Current EBITDA$2.6M
+ RCM Uplift+$1.7M
Pro Forma EBITDA$4.3M
Current Margin11.1%
Pro Forma Margin18.4%
WC Released (1x)$903K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.0M$34.5M8.61x53.8%
Base (11x exit)10.0x11.0x$4.0M$39.3M9.79x57.8%
Bull Case9.0x11.0x$3.6M$46.3M12.83x66.6%
Bull (12x exit)9.0x12.0x$3.6M$51.6M14.29x70.2%
Bear Case11.0x10.0x$4.4M$24.6M5.57x41.0%
Bear (11x exit)11.0x11.0x$4.4M$28.5M6.45x45.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 67.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 66 hospitals with 30-120 beds
  • Same-state prioritization (n=67)
  • Comp margins: P25=-20.9% / P50=-4.4% / P75=6.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.